Rani Therapeutics Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-15.0M | $-16.2M | $1.2M | — |
| FY2021 | $-32.2M | $-32.8M | $506.0K | $22.6M |
| FY2022 | $-46.5M | $-48.1M | $1.6M | $15.8M |
| FY2023 | $-51.2M | $-52.5M | $1.2M | $19.0M |
| FY2024 | $-35.5M | $-35.8M | $268.0K | $16.0M |
| FY2025 | $-18.7M | $-18.8M | $88.0K | $11.8M |